Who are Vitamin E ovules's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Methadone; NAC, High dose vitamin C, N Acetylcysteine A, NAC Bicarbonate, Thioctic acid, α-lipoic acid.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/vitamin-e-ovules.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Vitamin E ovules — Competitive Intelligence Brief

Vitamin E ovules (Vitamin E ovules) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antioxidant. Area: Cardiovascular.

phase 3 Antioxidant Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Vitamin E ovules (Vitamin E ovules) — Hospital General Universitario Elche. Vitamin E acts as an antioxidant, protecting cells from damage caused by free radicals.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Vitamin E ovules TARGET	Vitamin E ovules	Hospital General Universitario Elche	phase 3	Antioxidant
Methadone; NAC	Methadone; NAC	Taichung Veterans General Hospital	marketed	Opioid agonist with antioxidant adjunct	Mu opioid receptor (methadone); glutathione synthesis pathway (NAC)
High dose vitamin C	High dose vitamin C	Seoul National University Hospital	marketed	Vitamin/Antioxidant
N Acetylcysteine A	N Acetylcysteine A	Department of Medical Services Ministry of Public Health of Thailand	marketed	Mucolytic agent / Antioxidant	Glutathione synthesis pathway; mucus disulfide bonds
NAC Bicarbonate	NAC Bicarbonate	Seoul National University Hospital	marketed	Antioxidant/renal protective agent
Thioctic acid	Thioctic acid	The Dana Foundation	marketed	Antioxidant; mitochondrial cofactor
α-lipoic acid	α-lipoic acid	The Catholic University of Korea	marketed	Antioxidant; mitochondrial cofactor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antioxidant class)

All India Institute of Medical Sciences, Bhubaneswar · 1 drug in this class
Hospices Civils de Lyon · 1 drug in this class
Hospital General Universitario Elche · 1 drug in this class
Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vitamin E ovules — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-e-ovules. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab